Literature DB >> 16448704

Expression and role of Fc- and complement-receptors on human dendritic cells.

Zsuzsa Bajtay1, Eszter Csomor, Noémi Sándor, Anna Erdei.   

Abstract

Dendritic cells (DCs) are professional antigen presenting cells, which take up pathogens/foreign structures in peripheral tissues, then migrate to secondary lymphoid organs where they initiate adaptive immune responses by activating naive T-cells. In the early phase of antigen uptake pattern recognition receptors (including mannose-, scavenger- and toll-like receptors) that recognize pathogen-associated molecular patterns play an important role. Later receptors binding opsonized antigen are also involved in phagocytosis. These cell membrane molecules include various Fc-receptors, recognizing different isotypes of antibodies and various complement-receptors, such as CR3, CR4 and the C1q-binding complex of calreticulin and CD91. Here we aim to summarize how these immunecomplex binding receptors are involved in the initiation of DC maturation, and how they influence antigen presentation as well as some additional functions of these cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16448704     DOI: 10.1016/j.imlet.2005.11.023

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  24 in total

Review 1.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

2.  Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.

Authors:  Waranyoo Phoolcharoen; Seong H Bhoo; Huafang Lai; Julian Ma; Charles J Arntzen; Qiang Chen; Hugh S Mason
Journal:  Plant Biotechnol J       Date:  2011-02-01       Impact factor: 9.803

3.  Activation outcomes induced in naïve CD8 T-cells by macrophages primed via "phagocytic" and nonphagocytic pathways.

Authors:  Isabel María Olazabal; Noa Beatriz Martín-Cofreces; María Mittelbrunn; Gloria Martínez del Hoyo; Balbino Alarcón; Francisco Sánchez-Madrid
Journal:  Mol Biol Cell       Date:  2007-12-12       Impact factor: 4.138

4.  Immunogenicity of protein therapeutics: The key causes, consequences and challenges.

Authors:  Matthew P Baker; Helen M Reynolds; Brooke Lumicisi; Christine J Bryson
Journal:  Self Nonself       Date:  2010-10

5.  NEGATIVE REGULATORY EFFECTS OF PHOSPHATIDYLINOSITOL3-KINASE PATHWAY ON PHAGOCYTOSIS AND MACROPINOCYTOSIS IN BOVINE MONOCYTES.

Authors:  Mais G Ammari; Autumn N Harris; John V Stokes; Richard H Bailey; Lesya M Pinchuk
Journal:  J Vet Med Res       Date:  2014-08-31

6.  Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.

Authors:  Andrew G Diamos; Dalia Larios; Lauren Brown; Jacquelyn Kilbourne; Hyun Soon Kim; Divyasha Saxena; Kenneth E Palmer; Hugh S Mason
Journal:  Vaccine       Date:  2018-11-17       Impact factor: 3.641

7.  Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity.

Authors:  Kinga K Hosszu; Frances Santiago-Schwarz; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Innate Immun       Date:  2009-08-26       Impact factor: 2.680

8.  Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.

Authors:  Kobporn Boonnak; Bonnie M Slike; Timothy H Burgess; Randall M Mason; Shuenn-Jue Wu; Peifang Sun; Kevin Porter; Irani Fianza Rudiman; Djoko Yuwono; Pilaipan Puthavathana; Mary A Marovich
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

Review 9.  Fc-receptors and immunity to malaria: from models to vaccines.

Authors:  R J Pleass
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

10.  Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study.

Authors:  Guillaume Cartron; Lu Zhao-Yang; Marion Baudard; Tarik Kanouni; Valérie Rouillé; Philippe Quittet; Bernard Klein; Jean-Francois Rossi
Journal:  J Clin Oncol       Date:  2008-04-21       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.